DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA
Abstract
Abstract— Microscopic fluorescence photometry incorporating a light‐sensitive thermo‐electrically cooled charge‐coupled device (CCD) camera was employed to investigate the fluorescence distribution of 5‐aminolevulinic acid (ALA)‐induced porphyrins in 22 patients with a total number of 52 noduloul‐cerative basal cell carcinomas (BCC) after topical ALA application with or without dimethylsulfoxide (DMSO)/ethylenediaminetetraacetic acid (EDTA) or after intravenous administration of ALA. Both localization patterns and amounts of ALA‐induced porphyrins in the BCC were studied. The ALA‐induced porphyrins were localized only in the superficial layers of the noduloulcerative BCC lesions after topical application of 20% ALA alone for 3 h. However, both the penetration of ALA into deep lesions and the production of the ALA‐induced porphyrin fluorescence were increased after topical administration of 20% ALA and 20% DMSO/4% EDTA for 3 h. Prior treatment with 99% DMSO for 15 min further enhanced the ALA penetration into the BCC lesions after topical application of the ALA/DMSO/EDTA mixture and produced more ALA‐induced porphyrins by a factor of about three compared with those treated with ALA alone. The penetration of ALA into the deep BCC lesions could also be increased by prolonging the time of topical application of 20% ALA/4% EDTA to 29–48 h (without DMSO). Intravenous injection of ALA led to a more homogeneous distribution of the ALA‐derived porphyrins in the whole noduloulcerative BCC lesions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
EDTA does not increase PpIX production in a mouse tumor model and BCC patients after ALA administration, and DFO does not enhance PpIX fluorescence in skin cancer patients.
“Despite these promising results from many in vitro studies, EDTA does not increase PpIX production in a mouse tumor model [102] and BCC patients [103] after ALA administration, and DFO does not enhance PpIX fluorescence in skin cancer patients either [104].”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [103]
Cites
Photodynamic therapy with endogenous protoporphyrin
Kennedy, J. C., Pottier, R. H., & Pross, D. C. (1990) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(90)85083-9 · Cited by 1,509 · see citing works
Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase
Dailey, H. A., & Smith, A. (1984) · Biochemical Journal · doi:10.1042/bj2230441 · Cited by 140 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Angell-Petersen, E., Sørensen, R., Warloe, T., Soler, A. M., Moan, J., Peng, Q., & Giercksky, K.-E. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700048 · Cited by 123 · see citing works
5-Aminolevulinic Acid-Conjugated Gold Nanoparticles for Photodynamic Therapy of Cancer
Khaing Oo, M. K., Yang, X., Du, H., & Wang, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.777 · Cited by 113 · see citing works
Choudry, K., Brooke, R. C. C., Farrar, W., & Rhodes, L. E. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05351.x · Cited by 65 · see citing works
Wennberg, A.-M., Larkö, O., Lönnroth, P., Larson, G., & Krogstad, A.-L. (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00652.x · Cited by 48 · see citing works
5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy
Howley, R., Chandratre, S., & Chen, B. (2023) · Bioengineering · doi:10.3390/bioengineering10040496 · Cited by 33 · see citing works
Palasuberniam, P., Kraus, D., Mansi, M., Braun, A., Howley, R., Myers, K. A., & Chen, B. (2019) · Photochemistry and Photobiology · doi:10.1111/php.13091 · Cited by 23 · see citing works
- Authors
- Peng, Q., Warloe, T., Moan, J., Heyerdahl, H., Steen, H. B., Nesland, J. M., & Giercksky, K.
- Venue
- Photochemistry and Photobiology
- Publisher
- Wiley
- Published
- 1995-11
- Volume
- 62
- Issue
- 5
- Pages
- 906-913
- ISSN
- 0031-8655 (ISSN-L)
- 1751-1097
- OpenAlex
- W2100592740
- Cited by
- 178
- References
- 2
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2 · 2022: 2 · 2019: 2 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 3
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Photochemistry and Photobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Nonmelanoma Skin Cancer Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
- Keywords
- 5-aminolevulinic acid, porphyrins, topical photodynamic therapy, dimethyl sulfoxide, EDTA, fluorescence distribution, superficial skin lesions
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aminolevulinic Acid, Carcinoma, Basal Cell, Basal Cell Carcinoma, Dimethyl Sulfoxide, Humans, Microscopy, Fluorescence, Middle Aged, Photochemotherapy, Porphyrins, Skin Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review